B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)

PRESS RELEASE

published on 02/25/2026 at 07:30, 5 months 23 days ago

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
BRAIN Biotech's Q1 25/26 results show revenue decline but improved EBITDA. Breakthrough Aurase Wound Gel by SolasCure for chronic wounds. BRAIN BioIncubator segment thrives

EBITDA BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
BRIEF

published on 01/14/2026 at 07:35, 7 months 6 days ago

BRAIN Biotech AG fait preuve de résilience face aux défis économiques de l'exercice 2024/25

Baisse Des Revenus BRAIN Biotech AG Contrôle Des Coûts Exercice Financier 2024/25 Incubateur BRAINBio
BRIEF

published on 01/14/2026 at 07:35, 7 months 6 days ago

BRAIN Biotech AG Shows Resilience Amid Economic Challenges in FY 2024/25

Revenue Decline BRAIN Biotech AG Cost Control Financial Year 2024/25 BRAINBioIncubator
PRESS RELEASE

published on 01/14/2026 at 07:30, 7 months 6 days ago

FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control
BRAIN Biotech AG reports FY 2024/25 financial results showing successful project monetization and cost control measures. Decline in revenues offset by strong cash position

Financial Results Revenue Decline BRAIN Biotech AG Cost Control Project Monetization
BRIEF

published on 09/03/2025 at 09:35, 11 months 17 days ago

BRAIN Biotech AG Names Johan Jansén-Storbacka as EVP

Biotechnology BRAIN Biotech AG Executive Appointment Johan Jansén-Storbacka Enzyme Products
BRIEF

published on 09/03/2025 at 09:35, 11 months 17 days ago

BRAIN Biotech AG nomme Johan Jansén-Storbacka au poste de vice-président exécutif

Biotechnologie BRAIN Biotech AG Nomination De L'exécutif Johan Jansén-Storbacka Produits Enzymatiques
PRESS RELEASE

published on 09/03/2025 at 09:30, 11 months 17 days ago

BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business
BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business on September 1, 2025, succeeding Rod Sears-Black. Johan brings 20+ years of biotechnology experience

BRAIN Biotech Executive Vice President Johan Jansén-Storbacka Enzyme Products Biocatalysts
BRIEF

published on 08/28/2025 at 07:35, 11 months 23 days ago

BRAIN Biotech Reports Solid Q3 Revenue Growth in BRAINBiocatalysts Segment

Financial Results BRAIN Biotech AG Enzyme Business BRAINBiocatalysts Q3 Revenue Growth
BRIEF

published on 08/28/2025 at 07:35, 11 months 23 days ago

BRAIN Biotech annonce une solide croissance de son chiffre d'affaires au troisième trimestre dans le segment BRAINBiocatalysts

Résultats Financiers BRAIN Biotech AG Entreprise D'enzymes CERVEAUBiocatalyseurs Croissance Du Chiffre D'affaires Au Troisième Trimestre
PRESS RELEASE

published on 08/28/2025 at 07:30, 11 months 23 days ago

BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts
BRAIN Biotech AG reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts. Despite economic challenges, the company shows positive EBITDA results

Financial Results EBITDA Revenue Growth BRAIN Biotech AG BRAINBiocatalysts

Published on 08/20/2026 at 15:30, 2 hours 35 minutes ago

Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/20/2026 at 15:15, 2 hours 50 minutes ago

Reporting Results for the Six Months Ended June 30, 2026
Published on 08/20/2026 at 15:00, 3 hours 5 minutes ago

Portfolio Update - Strategic Investment in Maravilla Oil and Gas
Published on 08/20/2026 at 15:00, 3 hours 5 minutes ago

Vox Royalty Enters into Binding Agreement to Acquire Australian Copper and Gold Royalty Portfolio
Published on 08/20/2026 at 14:35, 3 hours 30 minutes ago

Wi2Wi Reports 59% Revenue Growth to US$2.32M and Returns to Profitability with US$251K Net Income in Q2 2026

View all ACCESSWIRE

Published on 08/20/2026 at 17:45, 20 minutes ago

CTS EVENTIM generates double-digit increases in revenue and earnings in the first half of 2026
Published on 08/20/2026 at 16:20, 1 hour 44 minutes ago

Holding(s) in Company
Published on 08/20/2026 at 15:45, 2 hours 19 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/20/2026 at 15:45, 2 hours 20 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 08/20/2026 at 15:44, 2 hours 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc

View all EQS

Published on 08/18/2026 at 18:00, 2 days ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 2 days ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 2 days 6 hours ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 2 days 6 hours ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 22 hours ago

Aéroports de Paris S.A - July 2026 traffic figures

View all LES ECHOS COMFI WIRE

News